Test Overview
Test Methodology

Real-Time Reverse Transcription Polymerase Chain Reaction (PCR)/DNA Probe Hybridization

Test Usage

Provides qualitative detection of Zika virus RNA from urine collected during the acute phase of infection.
This test is intended for the evaluation of pregnant women and symptomatic nonpregnant individuals with potential exposure to Zika virus.

Reference Range *

Negative

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Test Details
Days Set Up
Tuesday, Thursday
Analytic Time

6 - 10 days

Soft Order Code
RZIKU
Laboratory
Sendout
Reference Laboratory
Mayo RZIKU
Section
Special Testing
Specimen Requirements
Collection Instructions

Collect random urine in a sterile container and refrigerate.

Normal Volume
1 mL urine
Minimum Volume
0.3 mL urine
Additional Information

Due to similar clinical presentations, testing for RNA or IgM-class antibodies to dengue and chikungunya viruses, concurrently with Zika virus testing, is strongly recommended. For the most up-to-date Zika epidemiology and testing recommendations, visit www.cdc.gov/zika/. Test sent to Mayo Medical Laboratories.

Billing
CPT Code
87662
Fee Code
AA379
Resources